Evidence map›Paper›PMID 31182750›Full record

ArticleScientific reports2019

Nanofiber-expanded human CD34

Suman Kanji, Manjusri Das, Matthew Joseph, Reeva Aggarwal, Sudarshana M Sharma, Michael Ostrowski, Vincent J Pompili, Hai-Quan Mao, Hiranmoy Das

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Electrospun Nanofibers for Wound Management.ChemNanoMat : chemistry of nanomaterials for energy, biology and more · 2022
    Article
  14. Review
  15. Effect of composite biodegradable biomaterials on wound healing in diabetes.Frontiers in bioengineering and biotechnology · 2022
    Review
  16. Nanofiber-based systems intended for diabetes.Journal of nanobiotechnology · 2021
    Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Suman KanjiDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA.
Manjusri DasDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA.
Matthew JosephDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA.
Reeva AggarwalDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA.
Sudarshana M SharmaHollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.ORCID http://orcid.org/0000-0002-9745-0061
Michael OstrowskiHollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.ORCID http://orcid.org/0000-0003-2948-6297
Vincent J PompiliDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA.
Hai-Quan MaoInstitute for NanoBioTechnology, Department of Materials Science and Engineering, Johns Hopkins University, Whiting School of Engineering, Baltimore, MD, USA.
Hiranmoy DasDepartment of Internal Medicine, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA. hiranmoy.das@ttuhsc.edu.ORCID http://orcid.org/0000-0002-3343-0096
The Ohio State University Wexner Medical Center · USMedical University of South Carolina · USTexas Tech University · USJohns Hopkins University · US

Funding

Myeloid KLF2 regulation mechanisms in rheumatoid arthritisR01AR068279 · NIAMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI DAS, HIRANMOY · 2016 to 2022
$1.7M
Corneal Endothelial Stem Cells for Treatment of Corneal Endothelial DystrophiesR41EY024217 · NEI · RASHMIVU, LLC · PI DAS, HIRANMOY · 2014 to 2016
$268k
Nanofiber Expanded CD34+ Stem Cells for Osteoporosis TherapyR41AG057242 · NIA · HNB THERAPEUTICS, LLC · PI DAS, HIRANMOY · 2018 to 2018
$225k
NEI NIH HHS R41 EY024217NIAMS NIH HHS R01 AR068279NIA NIH HHS R41 AG057242
6 · The paper itself

Abstract

Despite advances in diabetic wound care, the significant number of amputations that occur every year demands more effective therapeutics. Herein, we offer an aminated polyethersulfone nanofiber-expanded human umbilical cord blood-derived CD34

Indexed as

Wound HealingAnimalsAntigens, CD34Cell LineCell ProliferationCollagenDermisDiabetes Mellitus, ExperimentalExtracellular MatrixFetal BloodFibroblastsGranulation TissueHumansInflammationMatrix MetalloproteinasesMice, Inbred NODAntigens, CD34CollagenMatrix MetalloproteinasesNF-kappa BStreptozocinTumor Necrosis Factor-alpha

Identifiers

PMID31182750
PMCPMC6557810
OpenAlexW2950984693

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.